The Use of an Online Learning and Consent Platform in Infertility Treatment
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · May 22, 2019
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
Participants: This will be a multi-center trial with each center planning on recruiting 100 couples. Half of the couples will be planning on undergoing ovulation induction with insemination (OI/IUI) and the other half in-vitro fertilization (IVF).
Procedures (methods): This is a multi-center prospective randomized controlled trial where couples undergoing OI/IUI or IVF will be randomized to receiving the current traditional standard of in-person treatment teaching by their physician and nursing team with standard paper consents or to the identical process of in-person teaching with the add...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female subjects must be 18-49 years of age undergoing fertility treatment
- • Able to give Informed Consent
- Exclusion Criteria:
- • Patients who do not have adequate command of the English language to provide informed consent
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winter Park, Florida, United States
Madison, Mississippi, United States
Raleigh, North Carolina, United States
Patients applied
Trial Officials
Linnea R Goodman, MD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials